Reuters logo
BRIEF-Genocea Biosciences reports qtrly loss per share $‍0.54​
2017年8月9日 / 下午12点50分 / 2 个月内

BRIEF-Genocea Biosciences reports qtrly loss per share $‍0.54​

Aug 9 (Reuters) - Genocea Biosciences Inc

* Genocea Biosciences reports second quarter 2017 financial results

* Genocea Biosciences Inc - Qtrly loss per share $‍0.54​

* Q2 earnings per share view $-0.47 -- Thomson Reuters I/B/E/S

* Genocea Biosciences - ‍Expects existing cash, cash equivalents are sufficient to support operating expenses and capital expenditure requirements into 2018​

* Genocea Biosciences Inc - ‍Is currently exploring various avenues to secure capital to advance GEN-003 into phase 3 trials​

* Genocea Biosciences Inc - ‍Does not intend to commence phase 3 development of GEN-003 until it has secured such capital. Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below